| |
| |
|
| Insider
Information: |
Junius Daniel M |
| Relationship: |
|
| City: |
Groton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
286,488 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,459,798 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
286,488 |
|
|
| Total
Value |
$7,459,798 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
7
|
|
Stock
price went up :
|
2
|
4
|
| Stock
price went down : |
1
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
1.3
|
| Percentage
Gain/Loss : |
 21.7%
|
95.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunogen Inc |
IMGN |
Director |
2018-03-16 |
184,987 |
2007-08-15 |
0 |
Premium* |
|
|
Idexx Laboratories Inc |
IDXX |
Director |
2024-01-30 |
3,042 |
|
0 |
Premium* |
|
|
Glycomimetics Inc |
GLYC |
|
2024-03-29 |
98,459 |
2016-12-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2013-12-10 |
4 |
S |
$15.11 |
$226,695 |
D/D |
(15,000) |
73,336 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2014-02-18 |
4 |
S |
$16.26 |
$243,923 |
D/D |
(15,000) |
80,636 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2014-03-17 |
4 |
S |
$16.40 |
$246,000 |
D/D |
(15,000) |
80,636 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2015-05-07 |
4 |
S |
$8.02 |
$9,744 |
D/D |
(1,215) |
141,805 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2017-02-08 |
4 |
S |
$141.75 |
$425,264 |
D/D |
(3,000) |
2,495 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2018-02-13 |
4 |
S |
$10.01 |
$467,253 |
D/D |
(46,667) |
196,700 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2018-02-20 |
4 |
S |
$11.68 |
$292,000 |
D/D |
(25,000) |
196,700 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2018-02-21 |
4 |
S |
$12.00 |
$140,556 |
D/D |
(11,713) |
184,987 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2018-02-28 |
4 |
S |
$190.06 |
$565,232 |
D/D |
(2,974) |
2,628 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2018-03-16 |
4 |
S |
$12.02 |
$300,405 |
D/D |
(25,000) |
184,987 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2020-05-19 |
4 |
S |
$295.61 |
$1,182,433 |
D/D |
(4,000) |
2,834 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2020-08-20 |
4 |
S |
$382.61 |
$1,424,063 |
D/D |
(3,722) |
2,847 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-02-22 |
4 |
S |
$538.57 |
$1,022,207 |
D/D |
(1,898) |
2,875 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-05-21 |
4 |
S |
$539.57 |
$1,348,918 |
D/D |
(2,500) |
2,886 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-08-10 |
4 |
S |
$679.58 |
$1,632,355 |
D/D |
(2,402) |
2,896 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2022-12-05 |
4 |
S |
$424.91 |
$1,294,276 |
D/D |
(3,046) |
2,968 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2023-02-16 |
4 |
S |
$511.68 |
$1,119,044 |
D/D |
(2,187) |
2,982 |
0 |
% |
|
117 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
